Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Interleukin 23 (compound)
Most Correlated Studies
- Expression data for effector T cells
- CD4+ T cells activated and differentiated with Th17-inducing cytokine combinations
- Th17 cells deficient for Sgk1 and treated with IL23
- CD4+ T cells differentiation into Th17 cells in the presence of TGF-beta1 and IL-6
- Innate lymphoid cells (ILCs) stimulated with cytokines and/or NKp44 antibody
Most Relevant Literature
- IL-23 to see: Gut DCs shine bright in inductive sites.
- Gums make IL-23, no professionals needed.
- Epithelial-derived interleukin-23 promotes oral mucosal immunopathology.
- IL-23 stabilizes an effector Treg cell program in the tumor microenvironment.
- A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response.
Most Relevant Clinical Trials
- Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy
- The Effect of Acupuncture on the Treatment of Endovenous Ablation on Pain, IL17 and IL 23
- Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
- The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of I…
- Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
